Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients - Wikidata - wikimedia - TriplyDB

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

http://www.wikidata.org/entity/Q34084546

about

Role of insulin in the type 2 diabetes therapy: past, present and future Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review Diabetes and cancer: two diseases with obesity as a common risk factor The metabolic and mitogenic properties of basal insulin analogues Impact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10 Cancer biology in diabetes.Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study.Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data.Insulin glargine and cancer risk in patients with diabetes: a meta-analysis.Electronic medical record cancer incidence over six years comparing new users of glargine with new users of NPH insulin Metformin and cancer occurrence in insulin-treated type 2 diabetic patients.Cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in Shanghai Insulin glargine versus other types of basal insulin-clinical and tumor characteristics in patients with breast carcinoma.Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.Cancer specific mortality in insulin-treated type 2 diabetes patients.Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort.Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study.Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.Impaired glucose metabolism treatment and carcinogenesis.Clinical benefits of metformin in gynecologic oncology.Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Insulin analogs and cancer.Insulin therapy and cancer in type 2 diabetes.Shared Risk Factors in Cardiovascular Disease and Cancer.Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin.Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.Human insulin does not increase bladder cancer risk.Controversies in the use of insulin analogues.Glucose metabolism disorders and the risk of cancer.Special considerations with insulin therapy in older adults with diabetes mellitus.Insulin therapy in diabetes and cancer risk: current understanding and implications for future study: proceedings from a meeting of a European Insulin Safety Consensus Panel, convened and sponsored by Novo Nordisk, held Tuesday October 5, 2010 at Th Diabetes and cancer relationships.Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?Antihyperglycaemic therapies and cancer risk.Long-term effects of insulin glargine on the risk of breast cancer.

P2860

Q22241148-CCCDED5E-9766-4598-A96F-50E0FB479CF2 Q24630395-C15053CA-32A9-4819-B248-0E069611504D Q26822753-78D787A3-DABA-4EA1-9631-8B7F386C3407 Q26991486-25FC5A4A-07A2-443E-A958-3FB87FB76D62 Q28535372-171D763F-4ABC-4116-8595-7F8CDF9D6B38 Q28730070-DECFE330-D810-4F88-A28F-277A7C488D82 Q33608038-41513C93-3CE1-44B2-A55D-5CA79FA539AF Q33954827-81749C62-E853-4962-A347-5498620B715E Q34069086-3E737C74-3776-45F0-9DFE-0C3B61D8361C Q34086275-01647EDB-34CA-45FF-9211-8649879B6746 Q34320632-784299FF-931B-46B1-9B36-C1B6C37D7330 Q34373861-F64E1572-FE80-494A-8EDF-414055430F2C Q34421989-5D1181FC-8AC2-466D-A6BD-0AAE05296F7B Q34545045-20E69032-3B54-4CF8-BD13-9005814DAB3A Q35019233-B8D889B5-85D4-4947-A2BF-ECB729531CA5 Q35038355-9CED2B59-E2A3-42A4-865D-3A7EF5EDEE91 Q35104958-5C4191D8-795F-4C49-BB64-B57CEAF6811E Q35131192-863AE1F8-6FDF-4D8B-8383-45BDDFC7C41D Q35154853-A032E899-DF06-4B30-B1BB-C0F7EB099BF8 Q35179836-D32EC1F4-5A77-4C3A-A36B-789045D45092 Q35587424-01319D7D-7101-41C8-B43E-D5F52D438AB9 Q35809936-636FFE5A-9965-4686-AE8F-51FD4505C5AA Q35832508-DF54B82C-E550-4641-8096-B6C570B8370A Q35870409-DBCFD992-7F35-4904-831E-127E210E9DC9 Q35871269-02AF10B8-2933-4E53-8CB4-97DA2F171496 Q35937961-6F92C7B0-DB03-4138-8772-73F9509BF403 Q35971416-1BC2F386-851B-45B1-9905-1DBEB843C948 Q36417868-3DECAE53-0CEC-47C5-8053-DAA8814A88F9 Q36709155-B3409D94-390B-4BEA-8A41-5EF10C98DBDC Q37278227-EF30BD9E-01EE-4FC4-8411-CDE88BF620C1 Q37331188-AB1C085D-56A8-4C92-AD86-CC1DFE82FD23 Q37496102-AB20099C-1624-458A-9DE8-7DDB822EE728 Q37827161-ECF9ED3E-C1D4-454F-9ED2-D95187AF3FDE Q37859317-C8C4B5D3-2537-4B07-84AC-DFF6D4B754F1 Q37884564-2211470F-F970-4B98-B899-11378EE4D5B5 Q37921639-D27A10C8-8876-45E7-BAD0-2C50AAAC4DC7 Q38097984-5CAFA3A6-DC03-447A-8FD2-EECF7B8E029F Q38239532-0578FF2D-AA77-4582-9A33-8335D7F338BA Q38250719-16D94CB3-F94B-4D3B-AE89-D642DB41F441 Q38438554-2CE745E8-0736-4C6E-A7A4-4358BECD9639

P2860

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

http://www.wikidata.org/entity/Q34084546

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Doses of insulin and its analo ...... eated type 2 diabetic patients

@ast

Doses of insulin and its analo ...... eated type 2 diabetic patients

@en

Doses of insulin and its analo ...... eated type 2 diabetic patients

@nl

type

label

Doses of insulin and its analo ...... eated type 2 diabetic patients

@ast

Doses of insulin and its analo ...... eated type 2 diabetic patients

@en

Doses of insulin and its analo ...... eated type 2 diabetic patients

@nl

prefLabel

Doses of insulin and its analo ...... eated type 2 diabetic patients

@ast

Doses of insulin and its analo ...... eated type 2 diabetic patients

@en

Doses of insulin and its analo ...... eated type 2 diabetic patients

@nl

P1433

Q34084546-08256B2B-C45B-45DE-8D39-6267C687F52A

P1476

Q34084546-A6C528F0-257A-4F88-860E-951A66F95DFA

P2093

Q34084546-1F5A5507-8361-48AC-AFC9-F00C12D0BBD1

Q34084546-2B19A552-6D3D-475D-93F6-AC450573664A

Q34084546-3BE9A90D-3458-4854-91E3-6FEF9CECEA6D

Q34084546-4B5AEB60-8A8D-4A02-951F-C4B8DCE23997

Q34084546-4EAFBDA0-E872-4802-B111-2D455B0444B8

Q34084546-57704462-47C5-48AF-92DD-814A5D8DA8C1

Q34084546-6C0F4601-1FA8-4F3B-97D7-FF860BC0DADB

Q34084546-6E968C3A-B9B2-48AE-8F9F-68BF45DC87D8

Q34084546-7DCFA180-9CA6-4481-BCDE-67D738ED0566

Q34084546-898A99A3-31D2-41EB-BB5E-7C559C0BDFFC

P2860

Q34084546-189D52C1-3FBF-414A-BA12-8A1C1D6E8A9E

Q34084546-25AB0FBD-3B0C-45B0-8461-E5B3453E8FB2

Q34084546-41D36426-2090-4344-8DDC-6C8D71880D93

Q34084546-5413AE20-3BB2-43D6-AD4E-68C6C1DE5B5A

Q34084546-5EC31B1B-45F8-4D51-8C60-26D0274164AE

Q34084546-5EC61C07-9C20-488D-AC45-FCBA8473665F

Q34084546-63DA36EA-2422-4AD2-A8E2-72521DAEEC1C

Q34084546-647F99F1-D3ED-427A-8186-6C465CEAEF97

Q34084546-6C7012EA-8357-41B3-AC2F-2250A7175591

Q34084546-72ED36F7-E20A-4E10-A10A-A1DB56093FE1

P304

Q34084546-3BD7D253-F556-4FD2-A899-0589FB19EBC0

P31

Q34084546-D6CC3E4A-203D-49A6-8877-B3CDA28A3922

P356

Q34084546-511C5AC7-CD14-4D5F-B617-8C5D253BC566

P407

Q34084546-522E2164-B561-4337-A6C0-F48EC09A8817

P433

Q34084546-B8F93BD7-7F32-4136-A25E-9CBCAB1C2BE0

P478

Q34084546-B073C38B-BFD4-4AE3-AA16-788239E6FE1A

P577

Q34084546-D6BF86D5-92E8-46B9-8469-235126AF25BA

P5875

Q34084546-5B7AC713-9697-4BA9-8969-7F6DBB1AEB79

P698

Q34084546-F05B5E94-0A8F-43A4-A4AF-1E0880A158CA

P921

Q34084546-B2439140-DBD5-4CBA-9AAB-1E38B379A06D

Q34084546-F68222BA-4748-4EBB-A55B-98BA17C4B548

P932

Q34084546-A1AD9CE6-86D1-4129-96FB-84592970962F

P356

P1433

P1476

Doses of insulin and its analo ...... eated type 2 diabetic patients

@en

P2093

Alessandro Barchielli

http://www.w3.org/2001/XMLSchema#string

Barbara Cresci

http://www.w3.org/2001/XMLSchema#string

Carlo Maria Rotella

http://www.w3.org/2001/XMLSchema#string

Caterina Lamanna

http://www.w3.org/2001/XMLSchema#string

Cecilia Melani

http://www.w3.org/2001/XMLSchema#string

Daniela Balzi

http://www.w3.org/2001/XMLSchema#string

Edoardo Mannucci

http://www.w3.org/2001/XMLSchema#string

Ilaria Bracali

http://www.w3.org/2001/XMLSchema#string

Laura Pala

http://www.w3.org/2001/XMLSchema#string

Matteo Monami

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

Metformin and reduced risk of cancer in diabetic patients

Long-acting insulin analogs.

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.

Sulphonylureas and cancer: a case-control study.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

Insulin glargine and malignancy: an unwarranted alarm.

P304

1997-2003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC10-0476

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44676033

http://www.w3.org/2001/XMLSchema#string

P698

20551014

http://www.w3.org/2001/XMLSchema#string

P921

P932

2928350

http://www.w3.org/2001/XMLSchema#string